Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang(Heidelberg University), Cun Wang(Shanghai Cancer Institute), Chunchao Zhu(Shanghai Jiao Tong University), Lei Xu(Shanxi University), Shengxian Yuan(Second Military Medical University), Xupeng Yang(Fudan University), Botai Li(Chinese Academy of Sciences), Chong Sun(Canadian Institute for Advanced Research), René Bernards(The Netherlands Cancer Institute), Hongye Wang(Guangzhou Experimental Station), Shuyi Ji(Fudan University), Qiang Gao(Southwestern University of Finance and Economics), Shangce Du(German Cancer Research Center), Haigang Geng(Shanghai Jiao Tong University), Ying Cao(Capital Normal University), Tangansu Zhang(Union Hospital), Haiyan Hu(Shanghai University of Traditional Chinese Medicine), Nuo Xu(Shanghai Jiao Tong University), Haoyu Zhang(Nanjing University of Information Science and Technology), Xiaoping Chen(Central South University), Yan Li(Shanghai Jiao Tong University), Hao Feng(National Institute of Child Health), Quan Zheng(Shanghai Jiao Tong University), Beiping Miao(German Cancer Research Center), Zhicheng Liu(Tongji Hospital), Si‐Si Zhang(Ningbo No. 2 Hospital), Lili Zhu(Henan University of Engineering), Xuhui Ma(Shanghai Jiao Tong University), Chune Yu(Shanghai Jiao Tong University), Xiangyu Tang(Tongji Hospital), Yuhan Xia(North Sichuan Medical University), Qian Li(Soochow University), Chuchen Zhu(Shanghai Jiao Tong University), Zhao Huang(Jinyintan Hospital), Hui Wang(Shanghai Jiao Tong University), Guang‐Zhi Jin(Second Military Medical University)
Cited by 70
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k